Bone marrow-derived mesenchymal stem cells (MSCs) are capable of self-renewal and differentiation into multiple cell lineages. Because of these capabilities, MSCs play an important role in continuous maintenance and repair of most tissue types. The quantity and quality of MSCs decrease with aging, which, in turn, is associated with the progressive failure of function of tissues and organs. Recently, we reported in mice that defects in the self-renewal and bone formation capacity of aged MSCs were completely restored by exposure to extracellular matrix (ECM) made by marrow stromal cells from young animals, and such improvement was substantially diminished when cells (from either young or old mice) were cultured on ECM made by old marrow stromal cells. This led us to investigate whether this phenomenon also occurs in humans. Indeed, our preliminary studies in human subjects clearly suggest that culturing aged MSCs on ECM made by young marrow stromal cells is able to improve their number and quality. The goal of this proposal is to determine the mechanisms whereby young ECM rejuvenates old bone marrow-derived MSCs. A unique, cell-free ECM model will be used to dissect how young ECM restores the functions of old MSCs in vitro and in vivo. The hypothesis proposed in this application is that age negatively impacts the formation of an ECM that normally preserves MSC function, and the quantity and quality of aged MSCs can be improved by exposure to an ECM made by stromal cells from young donors. We are uniquely-positioned to test this hypothesis in humans since, in addition to our strong preliminary data, up to 100 human bone marrow samples have been accumulated in the past three years from elders (60 to 96 years old). To test this hypothesis, we will systematically evaluate biological activities in viro and in vivo of young vs. old MSCs maintained on young- or old-ECM (Specific aim 1), and conduct proteomic analysis of young- and old-MSCs exposed to young- or old-ECM to elucidate the underlying changes at the protein level that are associated with the restored functions of the rescued cells (Specific aim 2). To fully understand the mechanisms underlying the influence of MSC behavior, we will determine the differences in the structures of young- vs. old-ECM including the architecture, mechanical properties, and protein composition (Specific aim 3). These studies are innovative in that we will have established, for the first time, a unique in vitr human model to examine effects of age on MSCs (intrinsic theory), and changes to MSCs by the surrounding ECM (extrinsic theory). Our studies are important from a translational point of view because they will provide key information that can facilitate the use of a patient's own (autologous) stem cells for cell- based therapies. In view of the fact that the elderly are the mai target population for this type of treatment, understating age-related changes in both MSCs and host is essential for improving the clinical outcome of transplanted autologous MSCs in old veteran.
According to the 2010 National Survey of Veteran Enrollees' Health and Reliance on VA, 45% of US Veteran population is 65 years or older, creating a major challenge for treating a large number of age-related diseases. The purpose of this application is to study whether adult mesenchymal stem cells (MSCs) undergo functional and molecular changes because of aging or aging is due to extrinsic environmental factors without any effect on the MSCs. The information gained from this study will lay the foundation to further study of the molecular complexity and dynamics of cell- extracellular matrix adhesions in regulation of MSC proliferation, survival, differentiation and migration, and will facilitate autologous stem cell-baed therapeutic applications.
|Block, Travis J; Marinkovic, Milos; Tran, Olivia N et al. (2017) Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies. Stem Cell Res Ther 8:239|
|Marinkovic, Milos; Block, Travis J; Rakian, Rubie et al. (2016) One size does not fit all: developing a cell-specific niche for in vitro study of cell behavior. Matrix Biol 52-54:426-441|
|Antebi, Ben; Zhang, ZhiLiang; Wang, Yu et al. (2015) Stromal-cell-derived extracellular matrix promotes the proliferation and retains the osteogenic differentiation capacity of mesenchymal stem cells on three-dimensional scaffolds. Tissue Eng Part C Methods 21:171-81|
|Zhang, Bin-Xian; Zhang, Zhi-Liang; Lin, Alan L et al. (2015) Silk fibroin scaffolds promote formation of the ex vivo niche for salivary gland epithelial cell growth, matrix formation, and retention of differentiated function. Tissue Eng Part A 21:1611-20|
|Rakian, Rubie; Block, Travis J; Johnson, Shannan M et al. (2015) Native extracellular matrix preserves mesenchymal stem cell ""stemness"" and differentiation potential under serum-free culture conditions. Stem Cell Res Ther 6:235|
|Antebi, Ben; Cheng, Xingguo; Harris, Jeffrey N et al. (2013) Biomimetic collagen-hydroxyapatite composite fabricated via a novel perfusion-flow mineralization technique. Tissue Eng Part C Methods 19:487-96|
|Yang, Wuchen; Guo, Dayong; Harris, Marie A et al. (2013) Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J Cell Sci 126:4085-98|